Advanced search    

Search: authors:"Christie M. Ballantyne"

56 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults

: Shuiqing Liu, Kunihiro Matsushita. Data curation: Ron C. Hoogeveen, Christie M. Ballantyne, Kunihiro Matsushita. Formal analysis: Shuiqing Liu, Esther D. Kim. Investigation: Shuiqing Liu, Esther D. Kim ... , Aozhou Wu, Michelle L. Meyer, Susan Cheng, Ron C. Hoogeveen, Christie M. Ballantyne, Hirofumi Tanaka, Gerardo Heiss, Elizabeth Selvin, Kunihiro Matsushita. Methodology: Shuiqing Liu, Kunihiro Matsushita

Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase

College of Medicine , Houston, TX , USA 1 Cardiovascular Research, Department of Medicine, Baylor College of Medicine , Houston, TX , USA 2 Christie M. Ballantyne 3 Center for Cardiovascular Disease ... conflict of interest. Christie M. Ballantyne declares consultant fees, grants, and research support from Esperion, paid to her institution, during the conduct of the study; she also declares grants

Causal Role of Alcohol Consumption in an Improved Lipid Profile: The Atherosclerosis Risk in Communities (ARIC) Study

Introduction Health benefits of low-to-moderate alcohol consumption may operate through an improved lipid profile. A Mendelian randomization (MR) approach was used to examine whether alcohol consumption causally affects lipid levels. Methods This analysis involved 10,893 European Americans (EA) from the Atherosclerosis Risk in Communities (ARIC) study. Common and rare variants in...

The Impact of Rapid Weight Loss on Oxidative Stress Markers and the Expression of the Metabolic Syndrome in Obese Individuals

. Ballantyne,2 and Ron C. Hoogeveen2 1Centre for Preventive Cardiology, 3rd Department of Internal Medicine, General Teaching Hospital and Charles University in Prague, U Nemocnice 2, 128 08 Prague 2, Czech

Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study

Background Advanced glycation end products and their cell-bound receptors are thought to mediate the adverse effects of vascular disease through oxidative stress, inflammation and endothelial dysfunction. We examined the association between the soluble form of receptor for advanced glycation end products (sRAGE) and kidney disease.

Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

OBJECTIVE Cardiovascular disease (CVD) is the major cause of morbidity and mortality in diabetes; yet, heterogeneity in CVD risk has been suggested in diabetes, providing a compelling rationale for improving diabetes risk stratification. We hypothesized that N-terminal prohormone brain natriuretic peptide (NTproBNP) and high-sensitivity troponin T may enhance CVD risk...

Elevated Plasma SPARC Levels Are Associated with Insulin Resistance, Dyslipidemia, and Inflammation in Gestational Diabetes Mellitus

Objective Recent studies suggested that secreted protein acidic and rich in cysteine (SPARC), a novel adipokine, is a key player in the pathology of obesity and type 2 diabetes. We aimed to determine whether concentrations of SPARC were altered in patients with gestational diabetes mellitus (GDM) compared to normal glucose tolerance (NGT) controls and to investigate the...

Elevated High-Sensitivity C-Reactive Protein as a Risk Marker of the Attenuated Relationship Between Serum Cholesterol and Cardiovascular Events at Older Age: The ARIC Study

The relationship between cholesterol and coronary heart disease (CHD) is attenuated at older age. We analyzed cholesterol level as a predictor of CHD in 8,947 participants from the Atherosclerosis Risk in Communities (ARIC) Study, a large multicenter cohort study that enrolled participants in 1987–1989 at 4 field centers in Washington County, Maryland; Forsyth County, North...

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

Background Icosapent ethyl (IPE) is a high-purity prescription form of eicosapentaenoic acid ethyl ester approved by the US Food and Drug Administration as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. In addition to TG-lowering effects, IPE also reduces non-high-density lipoprotein cholesterol and...

Effects of icosapent ethyl on lipid and inflammatory parameters in patients with diabetes mellitus-2, residual elevated triglycerides (200–500 mg/dL), and on statin therapy at LDL-C goal: the ANCHOR study

Background Icosapent ethyl (IPE) is a high-purity prescription form of eicosapentaenoic acid (EPA) ethyl ester indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia. ANCHOR was a 12-week, phase 3 study that evaluated the efficacy and safety of IPE in patients (N = 702) with residual high fasting TG...

Chronic inflammation role in the obesity-diabetes association: a case-cohort study

Background Chronic inflammation is related to both obesity and diabetes. Our aim was to investigate to what extent this inflammation contributes to the association between obesity and diabetes. Methods Using a case-cohort design, we followed 567 middle-aged individuals who developed diabetes and 554 who did not over 9 years within the ARIC Study. Weighted Cox proportional hazards...

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death

Elizabeth Selvin Marc K. Halushka Andreea M. Rawlings Ron C. Hoogeveen Christie M. Ballantyne Josef Coresh Brad C. Astor Advanced glycation end products (AGEs) and their receptors are strongly

NH2-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes

Mariana Lazo J. Hunter Young Frederick L. Brancati Josef Coresh Seamus Whelton Chiadi E. Ndumele Ron Hoogeveen Christie M. Ballantyne Elizabeth Selvin Brain natriuretic peptide (BNP) has an

Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples

Background Circulating lipoproteins and their protein constituents, apolipoproteins, are risk factors for chronic kidney disease (CKD). The associations between apolipoprotein A1, apolipoprotein B and their ratio with glomerular filtration rate estimated from the new CKD Epidemiology Collaboration (CKD-EPI) equation (eGFR) are not well studied in the general population.

Low-Density Lipoprotein Electronegativity Is a Novel Cardiometabolic Risk Factor

Background Low-density lipoprotein (LDL) plays a central role in cardiovascular disease (CVD) development. In LDL chromatographically resolved according to charge, the most electronegative subfraction–L5–is the only subfraction that induces atherogenic responses in cultured vascular cells. Furthermore, increasing evidence has shown that plasma L5 levels are elevated in...